Forget Bextra NEW ORLEANS - This morning, Pfizer was blindsided as The New York Times reported information about a reanalysis of old data that say the drug giant #39;s Bextra, which is similar to Merck #39;s Vioxx, increased the risk of heart attacks and strokes.